Chronic kidney disease mineral bone disorder in childhood and young adulthood: a ‘growing’ understanding
Open Access
- 25 August 2023
- journal article
- review article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 39 (3) , 723-739
Abstract
Chronic kidney disease (CKD) mineral and bone disorder (MBD) comprises a triad of biochemical abnormalities (of calcium, phosphate, parathyroid hormone and vitamin D), bone abnormalities (turnover, mineralization and growth) and extra-skeletal calcification. Mineral dysregulation leads to bone demineralization causing bone pain and an increased fracture risk compared to healthy peers. Vascular calcification, with hydroxyapatite deposition in the vessel wall, is a part of the CKD-MBD spectrum and, in turn, leads to vascular stiffness, left ventricular hypertrophy and a very high cardiovascular mortality risk. While the growing bone requires calcium, excess calcium can deposit in the vessels, such that the intake of calcium, calcium- containing medications and high calcium dialysate need to be carefully regulated. Normal physiological bone mineralization continues into the third decade of life, many years beyond the rapid growth in childhood and adolescence, implying that skeletal calcium requirements are much higher in younger people compared to the elderly. Much of the research into the link between bone (de)mineralization and vascular calcification in CKD has been performed in older adults and these data must not be extrapolated to children or younger adults. In this article, we explore the physiological changes in bone turnover and mineralization in children and young adults, the pathophysiology of mineral bone disease in CKD and a potential link between bone demineralization and vascular calcification. Graphical abstractKeywords
Funding Information
- Kidney Research UK (TF_002_20161124)
- National Institute for Health Research (CDF-2016-09-038)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (303545/2020–8)
This publication has 166 references indexed in Scilit:
- Mortality Risk Among Children Initially Treated With Dialysis for End-Stage Kidney Disease, 1990-2010JAMA, 2013
- Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium dietsKidney International, 2012
- Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney diseaseKidney International, 2011
- Renal osteodystrophy in the first decade of the new millennium: Analysis of 630 bone biopsies in black and white patientsJournal of Bone and Mineral Research, 2010
- Association of Changes in Bone Remodeling and Coronary Calcification in Hemodialysis Patients: A Prospective StudyAmerican Journal of Kidney Diseases, 2008
- The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not Matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysisNephrology Dialysis Transplantation, 2008
- Chronic kidney disease mineral and bone disorder in childrenPediatric Nephrology, 2007
- Vitamin D DeficiencyNew England Journal of Medicine, 2007
- Developmental regulation of the growth plateNature, 2003
- Mortality and causes of death of end-stage renal disease in children: A Dutch cohort studyKidney International, 2002